Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.7K Hold
78
– – 0.04% 242
2026
Q2
$41.3K Sell
78
-14
-15% -$6.46K 0.03% 254
2026
Q1
$44.2K Buy
92
+14
+18% +$7.17K 0.04% 238
2025
Q4
$43.8K Buy
+78
New +$44.3K 0.04% 244

Other funds holding MEDP

Bayban's MEDP Position: Q3 2026 in Review

Bayban held its Medpace (MEDP) position steady in Q3 2026 at 78 shares worth $48.7K. The position accounts for 0.04% of the portfolio, ranked #242.

Bayban first reported a position in MEDP in Q4 2025 and has held it in 4 quarters since. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Bayban held 78 shares of Medpace worth $48.7K as of Q3 2026.
  • Bayban left its Medpace share count unchanged in Q3 2026.
  • Medpace made up 0.04% of Bayban's portfolio in Q3 2026, its #242 holding.
  • Bayban first reported a position in Medpace in Q4 2025 and has held it in 4 quarters since.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.